Since the 2017 revisions to the McDonald criteria, many patients previously categorized as clinically isolated syndrome (CIS) can be reclassified as relapsing remitting MS with the additions of including symptomatic enhancing lesions and oligoclonal banding on CSF in dissemination in space and time ...